Plasma Steroids and Endocannabinoids Used as Biomarkers to Assess the Pruritus Severity of Patients With Prurigo Nodularis
Background: Prurigo nodularis (PN) as an extremely pruritic and hyperplastic chronic dermatosis induces psychologically and physiologically stressful responses. PN-induced responses in the hypothalamic-pituitary-adrenal (HPA), hypothalamic-pituitary-gonadal (HPG) axes and endocannabinoid system (ECS...
Saved in:
Main Authors: | L. Chu (Author), L.-K. Wang (Author), Y. Wu (Author), H. Yang (Author), W. Wang (Author), Q. Lu (Author), H. Deng (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tofacitinib for Prurigo Nodularis: A Case Report
by: Peng C, et al.
Published: (2022) -
Upadacitinib for prurigo nodularis
by: Clara Muntaner-Virgili, MD, et al.
Published: (2024) -
Recent advances in treatment of prurigo nodularis
by: Chieh-Hsun Chen, et al.
Published: (2024) -
[Artículo traducido] Esteroides y endocannabinoides plasmáticos utilizados como biomarcadores para evaluar la gravedad del prurito de los pacientes con prúrigo nodular
by: L. Chu, et al.
Published: (2022) -
Abnormal keratin expression pattern in prurigo nodularis epidermis
by: L. L. Yang, et al.
Published: (2022)